Press release
Comprehensive Tardive Dyskinesia Therapeutics Market Forecast 2025-2034: Growth Trends and Strategic Shifts
Tardive Dyskinesia Therapeutics
Tardive Dyskinesia Therapeutics Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market size for tardive dyskinesia treatments has seen a solid expansion in the past few years. It is projected to escalate from $2.9 billion in 2024 to $3.12 billion in 2025, marking a compound annual growth rate (CAGR) of 7.5%. Factors such as the increasing incidence of tardive dyskinesia, a rise in the worldwide count of schizophrenia and bipolar disorder patients, enhanced awareness and diagnoses, growing utilization of atypical and typical antipsychotic drugs, and an aging population have all contributed to the growth henceforth experienced.
Tardive Dyskinesia Therapeutics Market Size Forecast: What's the Projected Valuation by 2029?
The market for tardive dyskinesia therapeutics is slated to witness robust expansion in the upcoming years, escalating to a value of $4.11 billion by 2029, growing at a compound annual growth rate (CAGR) of 7.2%. Factors that contribute to this growth during the forecast period include the increase in mental health disorders, expansion of research and development endeavours, escalating investments from pharmaceutical firms, a rising trend towards personalized medicine, and enhancements in healthcare infrastructure. The forecast period is also likely to see key trends such as strategic collaborations between pharmaceutical companies and research institutions for innovative therapies, the creation of extended-release formulation, the rise of generic options, regulatory benefits like orphan drug designation, and technological progress in drug delivery mechanisms.
View the full report here:
https://www.thebusinessresearchcompany.com/report/tardive-dyskinesia-therapeutics-global-market-report
What Are the Drivers Transforming the Tardive Dyskinesia Therapeutics Market?
The upsurge in mental health disorders is anticipated to stimulate the expansion of the tardive dyskinesia therapeutics market. Such disorders, which impact an individual's feelings, thoughts, actions, or daily functionality, are becoming more prevalent, given the rise in social isolation. This has been amplified by the shift towards digital interactions and the fast-paced nature of modern life reducing in-person connections and thus generating increased feelings of solitude and emotional stress. Therapies for tardive dyskinesia can aid individuals with mental disorders by controlling involuntary movement symptoms associated with prolonged antipsychotic usage. This, in turn, enhances treatment compliance and overall life quality. For example, data from the National Alliance On Mental Illness based in the US confirmed that of the individuals between the ages of 18-44 in the U.S., psychosis spectrum and mood disorders resulted in approximately 600,000 hospitalizations annually in 2024. Consequently, the rising prevalence of mental health disorders is a key driver for the tardive dyskinesia therapeutics market.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24718&type=smp
What Long-Term Trends Will Define the Future of the Tardive Dyskinesia Therapeutics Market?
Leading firms in the tardive dyskinesia therapeutics market are prioritizing the creation of innovative products like once-daily treatment alternatives to ensure constant drug levels in patients. Once-daily treatment alternatives include medications or therapies that are taken once a day, making dosage schedules easier and increasing patient compliance. In May 2024, Teva Pharmaceutical Industries Limited, a biopharmaceutical firm based in Israel, revealed that the U.S. Food and Drug Administration has authorized AUSTEDO XR tablets for treating adults with tardive dyskinesia and Huntington's disease chorea. The latest authorization of AUSTEDO XR provides patients with dependable effectiveness in controlling involuntary movements and the added advantage of a once-daily, single-pill dosage. This innovative formulation provides clinically therapeutic doses as confirmed by critical clinical trials. Furthermore, it is now accessible in four varying tablet strengths: 30 mg, 36 mg, 42 mg, and 48 mg.
Which Segments in the Tardive Dyskinesia Therapeutics Market Offer the Most Profit Potential?
The tardive dyskinesia therapeutics market covered in this report is segmented -
1) By Drug: Deutetrabenazine, Valbenazine, Other Drugs
2) By Product Type: Solid Dosage Forms, Tablets, Capsules, Liquid Dosage Form, Injection
3) By Application: Antipsychotic-Induced Tardive Dyskinesia, Other Drug-Induced Tardive Dyskinesia, Idiopathic Tardive Dyskinesia
4) By End-User: Hospitals, Clinics, Specialty Treatment Centers, Homecare Settings
Sub Segments:
1) By Deutetrabenazine: Dosage Forms, Line Of Therapy, Distribution Channel
2) By Valbenazine: Dosage Forms, Patient Age Group, Distribution Channel
3) By Other Drugs: Drug Class Or Type, Dosage Forms, Treatment Duration
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=24718&type=smp
Which Firms Dominate the Tardive Dyskinesia Therapeutics Market by Market Share and Revenue in 2025?
Major companies operating in the tardive dyskinesia therapeutics market are Pfizer Inc., Johnson & Johnson, AbbVie Inc., Novartis AG, Teva Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Co. Ltd., Sun Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories Ltd., Lundbeck A/S, Amneal Pharmaceuticals Inc., Lupin Pharmaceuticals Inc., Neurocrine Biosciences Inc., Luye Pharma Ltd., Lannett Co. Inc., SteriMax Inc., Zydus Cadila Healthcare Ltd., Adamas Pharmaceuticals Inc., Mitsubishi Tanabe Pharma Corporation, SOM Biotech Ltd., Addex Therapeutics
Which Regions Offer the Highest Growth Potential in the Tardive Dyskinesia Therapeutics Market?
North America was the largest region in the tardive dyskinesia therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the tardive dyskinesia therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=24718
This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Comprehensive Tardive Dyskinesia Therapeutics Market Forecast 2025-2034: Growth Trends and Strategic Shifts here
News-ID: 4092244 • Views: …
More Releases from The Business Research Company
Air Cargo And Freight Logistics Global Market Insights: Growth Drivers, Size & F …
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports.
What Is the Forecasted Market Growth Rate of the Air Cargo And Freight Logistics Industry?
The market size for air cargo and freight logistics has seen robust expansion in the past few years. The projection is that it will rise from $225.06 billion in 2024 to $240.65 billion in 2025, demonstrating…
Future of Two-wheeler Shock Absorber Market: Size, Share & Forecasts to 2029
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports.
What Is the Projected Market Size Valuation of the Two-wheeler Shock Absorber Market by 2025?
The market size of the two-wheeler shock absorber has witnessed consistent growth over the recent years. It is projected to expand from $3.29 billion in 2024 to $3.39 billion in 2025, registering a compound annual growth…
Solar Powered Car Industry to Achieve $8.7 Billion Growth by 2029
Get 30% off global market reports with code ONLINE30 and keep ahead of tariffs, macro trends, and worldwide economic developments.
How Will the Solar Powered Car Market Grow by 2025 in Terms of Size and Growth?
The market dimension of solar powered vehicles has undergone substantial growth in the past few years. It is projected to increase from $1.94 billion in 2024 to $2.58 billion in 2025, reflecting a compound annual growth…
Recreational Boating Market Growth to be Driven by Emerging Trends | $46.66 Bill …
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports.
What is the Projected Market Size of the Recreational Boating Industry?
The size of the recreational boating market has been on a steady rise over the past few years. This market is projected to escalate from $32.87 billion in 2024 to $34.94 billion in 2025, reflecting a compound annual growth rate…
More Releases for Tardive
Tardive Dyskinesia Treatment Market Analysis By Drug Class & Distribution Channe …
The Tardive Dyskinesia Treatment Market is expected to Reach a CAGR of 4% during the forecast period (2024-2031).
Tardive Dyskinesia Treatment Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative research methods, it…
Tardive Dyskinesia Market Report and Forecast 2024-2032
The tardive dyskinesia market size is anticipated to grow at a CAGR of 3.2 % during the forecast period of 2024-2032, driven by growing awareness about the importance of monitoring patients on long-term antipsychotic therapy for early signs of tardive dyskinesia in the major markets.
Tardive Dyskinesia: Introduction
Tardive dyskinesia is a neurological disorder characterized by involuntary, repetitive body movements. It primarily affects the face, causing grimacing, blinking, or lip-smacking, but can…
Global Tardive Dyskinesia (TD) Treatment Market - Opportunities & Forecasts, 202 …
Dhirtek Business Research and Consulting recently released its most comprehensive research report to date on the global tardive dyskinesia (td) treatment market. Through extensive research, analysts have provided an extensive look into the market's drivers and restraints, and identified the key milestones and trends that will shape its future.
Primary and secondary research methods were used to create this in-depth report. Through the analysis of the research, Dhirtek was able to…
Tardive Dyskinesia Drugs Market Competitor Landscape, Opportunity Analysis, Grow …
Tardive neurological disorder (TD) may be a kind of dyskinesia that's tough to treat. it's a nerve disorder characterised by involuntary movements like jaw, lips, and tongue, thought-about as grimacing, protrusive the tongue out, and lip smack. another symptoms square measure a private experiencing involuntary movement of the lower and higher extremities and additionally respiratory choking.
Get HOLISTIC Request Sample Copy:https://www.coherentmarketinsights.com/insight/request-sample/218
consistent with Center for Drug analysis and analysis, dyskinesia will…
Tardive Dyskinesia (TD) Treatment Drugs Market Size, Share, Development by 2024
LP INFORMATION offers a latest published report on Tardive Dyskinesia (TD) Treatment Drugs Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report.
According to this study, over the next five years the Tardive Dyskinesia (TD) Treatment Drugs market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$…
Antioxidants May Aid in the Treatment of Tardive Dyskinesia
Memphis, TN (May 9, 2019) – Today, The Primary Care Companion for CNS Disorders published a case report on the use of antioxidants in the treatment of tardive dyskinesia. While new pharmacologic discoveries have occurred in the area of movement disorders, their use comes with a large price tag. Thus, for mild cases, clinicians may want to seek out more cost-effective options. Antioxidants may serve a role in the prevention…
